CZ293919B6 - Prostředek schopný reagovat na magnetické pole - Google Patents

Prostředek schopný reagovat na magnetické pole Download PDF

Info

Publication number
CZ293919B6
CZ293919B6 CZ20021357A CZ20021357A CZ293919B6 CZ 293919 B6 CZ293919 B6 CZ 293919B6 CZ 20021357 A CZ20021357 A CZ 20021357A CZ 20021357 A CZ20021357 A CZ 20021357A CZ 293919 B6 CZ293919 B6 CZ 293919B6
Authority
CZ
Czechia
Prior art keywords
particles
iron
ceramic
composition
biologically active
Prior art date
Application number
CZ20021357A
Other languages
Czech (cs)
English (en)
Other versions
CZ20021357A3 (cs
Inventor
Rudgeáscottáraymond
Kurtzáterriálynn
Tapolskyágillesáhugues
Liáyuhua
Original Assignee
Ferxáincorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferxáincorporated filed Critical Ferxáincorporated
Publication of CZ20021357A3 publication Critical patent/CZ20021357A3/cs
Publication of CZ293919B6 publication Critical patent/CZ293919B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Paints Or Removers (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ20021357A 1999-10-18 2000-10-13 Prostředek schopný reagovat na magnetické pole CZ293919B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16029399P 1999-10-18 1999-10-18

Publications (2)

Publication Number Publication Date
CZ20021357A3 CZ20021357A3 (cs) 2002-11-13
CZ293919B6 true CZ293919B6 (cs) 2004-08-18

Family

ID=22576298

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20021357A CZ293919B6 (cs) 1999-10-18 2000-10-13 Prostředek schopný reagovat na magnetické pole

Country Status (15)

Country Link
EP (1) EP1221974A2 (ja)
JP (3) JP2003512336A (ja)
KR (1) KR20020064299A (ja)
CN (1) CN1287859C (ja)
AU (1) AU772755B2 (ja)
BR (1) BR0014877A (ja)
CA (1) CA2387925A1 (ja)
CZ (1) CZ293919B6 (ja)
DE (1) DE1221974T1 (ja)
ES (1) ES2182731T1 (ja)
HK (1) HK1045110A1 (ja)
IL (1) IL149004A0 (ja)
MX (1) MXPA02003891A (ja)
NZ (1) NZ518311A (ja)
WO (1) WO2001028587A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
WO2005025508A2 (en) * 2003-09-12 2005-03-24 Bankruptcy Estate Of Ferx, Inc. Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
JP4982084B2 (ja) * 2004-02-09 2012-07-25 株式会社サンギ 抗腫瘍剤
BRPI0507824A (pt) 2004-02-20 2007-07-10 Algeta As hidroxiapatita, processo para a preparação de um particulado de hidroxiapatita marcada com radionuclìdeo, composição farmacêutica, uso de hidroxiapatita e de um radionuclìdeo emissor de alfa ou um radionuclìdeo emissor de beta, dispositivo, e, método de tratamento radioquìmico de um ser humano ou de um indivìduo animal não humano necessitando do mesmo
GB0403856D0 (en) * 2004-02-20 2004-03-24 Algeta As Composition
JP2006199810A (ja) * 2005-01-20 2006-08-03 Yokohama National Univ 複合粒子およびその製造方法
WO2006109635A1 (ja) 2005-04-06 2006-10-19 Kabushiki Kaisha Sangi 腸管吸収用抗腫瘍剤
EP2427179A4 (en) 2009-05-04 2013-09-11 Psivida Inc POROUS PARTICLES FOR THE RELEASE OF SILICIUM MEDICINES
IN2013MN00758A (ja) 2010-11-01 2015-06-12 Psivida Inc
US20150252356A1 (en) * 2012-08-28 2015-09-10 Bio Cube System Co., Ltd. Porous solid phase for rapidly isolating biological molecules for nucleic acid amplification reaction from biological sample, and use thereof
JP2016512839A (ja) 2013-03-15 2016-05-09 シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． 治療物質の送達のための生体内分解性ケイ素系組成物
JP6443907B2 (ja) * 2014-02-17 2018-12-26 浩文 山本 造影剤の腫瘍への集積を促進するための集積促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243652A (en) * 1978-07-14 1981-01-06 The Procter & Gamble Company Gastrointestinal scanning agent
EP0343934B1 (en) * 1988-05-24 1995-01-25 Anagen (U.K.) Limited Magnetically attractable particles and method of preparation
JP3436760B2 (ja) * 1994-07-27 2003-08-18 ハーバート ピルグリム 超常磁性粒子
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
JP3735990B2 (ja) * 1997-01-28 2006-01-18 東ソー株式会社 磁性シリカゲルの製造方法

Also Published As

Publication number Publication date
MXPA02003891A (es) 2002-12-09
BR0014877A (pt) 2002-06-11
KR20020064299A (ko) 2002-08-07
NZ518311A (en) 2003-10-31
DE1221974T1 (de) 2003-02-06
CN1287859C (zh) 2006-12-06
JP2003321348A (ja) 2003-11-11
JP2003512336A (ja) 2003-04-02
CN1420787A (zh) 2003-05-28
AU1090501A (en) 2001-04-30
WO2001028587A3 (en) 2002-01-03
IL149004A0 (en) 2002-11-10
AU772755B2 (en) 2004-05-06
CA2387925A1 (en) 2001-04-26
HK1045110A1 (zh) 2002-11-15
CZ20021357A3 (cs) 2002-11-13
EP1221974A2 (en) 2002-07-17
ES2182731T1 (es) 2003-03-16
JP2005200426A (ja) 2005-07-28
WO2001028587A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
US6482436B1 (en) Magnetically responsive composition
AU744205B2 (en) Magnetically responsive composition
JP2005200426A (ja) 磁気標的化キャリア
US20200276230A1 (en) Particles for the treatment of cancer in combination with radiotherapy
US20060204442A1 (en) Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
JP2008514597A (ja) 放射性同位体を結合し得、任意選択的に金属微粒子を含むミクロスフェア、およびそれらの使用方法
JP6141341B2 (ja) 放射性標識合成ポリマーのための方法
US20030120355A1 (en) Biocompatible and biodegradable polymers for diagnostic and therapeutic radioisotope delivery
JPWO2011096230A1 (ja) 磁性粒子、及びその製造方法、並びに磁性粒子含有製剤
Johnson et al. The MTC technology: a platform technology for the site-specific delivery of pharmaceutical agents
Zhao et al. Thermochemotherapy mediated by novel solar-planet structured magnetic nanocomposites for glioma treatment
Guo et al. Efficient conjugation doxorubicin to bacterial magnetic nanoparticles via a triplex hands coupling reagent
US20070274907A1 (en) Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
Allen et al. MTCTM: A magnetically targetable drug carrier for Paclitaxel
Ferrari et al. Multistage delivery of active agents
WO2003059325A1 (en) Magnetic delivery compositions
WO2000035487A1 (en) Pharmaceutical conjugates comprising two active agents
JP2003501224A (ja) ヨウ素含有放射活性源

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 20071013